We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
Artificial Intelligence (AI) is rapidly transforming the pharmaceutical industry. From drug discovery and clinical trial optimization to medical writing and
The clinical research industry in Greece continues to attract pharmaceutical, biotechnology, and medical device companies seeking access to skilled healthcare
In today’s highly regulated pharmaceutical and life sciences environment, regulatory demands are expanding across every stage of the product lifecycle—from
The pharmaceutical industry continues to evolve through innovation, strategic partnerships, and global collaboration. One of the most anticipated events bringing
Clinical trials are the foundation of pharmaceutical, biotechnology, and medical device innovation. However, even the most promising therapies can face
Clinical trials have become increasingly complex, involving multiple sites, large volumes of data, decentralized trial models, and heightened regulatory expectations.
The Indian pharmaceutical industry has established itself as a global leader in generic drug manufacturing, active pharmaceutical ingredient (API) production,
Clinical trials have become increasingly complex. Sponsors face growing pressure to accelerate development timelines, manage multiple stakeholders, maintain regulatory compliance,
Regulatory compliance remains one of the most critical responsibilities for pharmaceutical, biotechnology, and life sciences companies. While product development and
The global generic pharmaceutical industry continues to grow as healthcare systems seek affordable alternatives to branded medicines. However, launching a
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was notable for the positive Phase 3 results of daraxonrasib (RMC-6236)
The global generic pharmaceutical industry continues to grow as healthcare systems seek affordable alternatives to branded medicines. However, launching a
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has posed significant challenges in oncology, with a five-year survival rate of approximately
Medical device innovation is advancing rapidly. From AI-powered diagnostic platforms to wearable monitoring technologies and implantable devices, manufacturers are bringing
The FDA regulatory landscape has significantly changed in 2026, marked by the removal of the two-trial requirement and the introduction
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Write to us : bd@zenovel.com
Copyright © 2026 Zenovel. All rights reserved.
